Cargando…

Differentiating founder and chronic HIV envelope sequences

Significant progress has been made in characterizing broadly neutralizing antibodies against the HIV envelope glycoprotein Env, but an effective vaccine has proven elusive. Vaccine development would be facilitated if common features of early founder virus required for transmission could be identifie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, John M., Maher, Stephen, Mota, Talia, Suzuki, Kazuo, Kelleher, Anthony D., Center, Rob J., Purcell, Damian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302377/ https://www.ncbi.nlm.nih.gov/pubmed/28187204 http://dx.doi.org/10.1371/journal.pone.0171572

Ejemplares similares

Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission
por: Mota, Talia M, et al.
Publicado: (2012)

P12-01. Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens
por: Reddy, S Mohana Rama, et al.
Publicado: (2009)

Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting
por: King, Hannah A. D., et al.
Publicado: (2019)

A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
por: Ananthaswamy, Neeti, et al.
Publicado: (2019)

HIV-1-Based Virus-like Particles that Morphologically Resemble Mature, Infectious HIV-1 Virions
por: Gonelli, Christopher A., et al.
Publicado: (2019)

A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence
por: Welbourn, Sarah, et al.
Publicado: (2022)

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes
por: O’Brien, Sean P., et al.
Publicado: (2019)

Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particles
por: Kirkegaard, Tea, et al.
Publicado: (2011)

Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies
por: Ratnapriya, Sneha, et al.
Publicado: (2023)

Immunogenicity of native and CD4 liganded monomeric and trimeric envelope glycoproteins based on HIV-1 Subtype C consensus Founder virus sequences
por: Killick, MA, et al.
Publicado: (2012)

HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses
por: Kafando, Alexis, et al.
Publicado: (2019)

In Memoriam: Jerome S. Brody, M.D., A Red Journal Founder
por: Center, David M., et al.
Publicado: (2023)

Vaccine-elicited systemic and mucosal humoral responses of lactating rhesus monkeys vaccinated with the transmitted/founder HIV Envelope 1086C
por: Fouda, G, et al.
Publicado: (2012)

Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes
por: Jain, S, et al.
Publicado: (2012)

Transmitted/Founder Simian Immunodeficiency Virus Envelope Sequences in Vesicular Stomatitis and Semliki Forest Virus Vector Immunized Rhesus Macaques
por: Gambhira, Ratish, et al.
Publicado: (2014)

Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env
por: Gonelli, Christopher A., et al.
Publicado: (2021)

Co-Expression of miRNA Targeting the Expression of PERK, but Not PKR, Enhances Cellular Immunity from an HIV-1 Env DNA Vaccine
por: Wheatley, Adam K., et al.
Publicado: (2011)

Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth
por: Smith, S. Abigail, et al.
Publicado: (2016)

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques
por: Santra, Sampa, et al.
Publicado: (2015)

Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys.
por: Himes, Jonathon E., et al.
Publicado: (2018)

HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders
por: Janes, Holly, et al.
Publicado: (2015)

Promoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription
por: Suzuki, Kazuo, et al.
Publicado: (2015)

Foundered
por: Hayes, P. H.
Publicado: (1876)

Efficient transcription through an intron requires the binding of an Sm-type U1 snRNP with intact stem loop II to the splice donor
por: Alexander, Marina R., et al.
Publicado: (2010)

Differential binding of the HIV-1 envelope to phosphatidylserine receptors
por: Gu, Linlin, et al.
Publicado: (2017)

Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response
por: Heydarchi, Behnaz, et al.
Publicado: (2016)

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein
por: Yu, Jingyou, et al.
Publicado: (2015)

Characterization of envelope sequence of HIV virus in children infected with HIV in Vietnam
por: Dang, Linh Vu Phuong, et al.
Publicado: (2020)

NGlyAlign: an automated library building tool to align highly divergent HIV envelope sequences
por: Akand, Elma H., et al.
Publicado: (2021)

Challenges of diagnostic exome sequencing in an inbred founder population
por: Azmanov, Dimitar N, et al.
Publicado: (2013)

The Founders of Neurology
por: Lewis, P. D.
Publicado: (1972)

Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env
por: Heydarchi, Behnaz, et al.
Publicado: (2016)

HIV-1 Expressing the Envelopes of Transmitted/Founder or Control/Reference Viruses Have Similar Infection Patterns of CD4 T-Cells in Human Cervical Tissue Ex Vivo
por: Merbah, Melanie, et al.
Publicado: (2012)

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
por: Foster, Toshana L., et al.
Publicado: (2016)

Native American Admixture in the Quebec Founder Population
por: Moreau, Claudia, et al.
Publicado: (2013)

Memory B Cells, the HLA-B*57 Allele and Natural Control of HIV Infection
por: Center, Rob J.
Publicado: (2017)

Drosophila Heartless Acts with Heartbroken/Dof in Muscle Founder Differentiation
por: Dutta, Devkanya, et al.
Publicado: (2005)

Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies
por: Kuriakose Gift, Syna, et al.
Publicado: (2023)

HIV latency reversing agents act through Tat post translational modifications
por: Khoury, Georges, et al.
Publicado: (2018)

Influence of Cytokines on HIV-Specific Antibody-Dependent Cellular Cytotoxicity Activation Profile of Natural Killer Cells
por: Wren, Leia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6k5g46m2gc7ausfc0ibuumc4ft